Fact CheckerSign in

NCT07183969Completed

The Effectiveness of Lower Extremity Strength Training

The Effectiveness of Lower Extremity Strength Training on the Physical Performance of Patients With Chronic Schizophrenia With Sarcopenia.

Source: ClinicalTrials.gov · Last updated 19 Sept 2025

Brief summary (registry, in English)

The increase in chronic schizophrenia patients with sarcopenia is currently an important healthcare issue in Taiwan and requires enhanced prevention and progress. Therefore, the purpose of this study was to understand the prevalence of sarcopenia in patients with chronic schizophrenia and to explore the effect of lower limb strength training on the physical functional performance of patients with chronic schizophrenia and sarcopenia. This study adopted a quasi-experimental design method, and the research process was divided into two stages. In the first stage, the SARC-CalF questionnaire was used to initially screen suspected chronic schizophrenia patients in a psychiatric hospital in central Taiwan. For sarcopenia cases, the skeletal muscle mass index (Skeletal Muscle Mass index) of suspected sarcopenia cases is further compared with the body composition analyzer (Inboby) to confirm the diagnosis of sarcopenia. Statistical analysis of the prevalence of sarcopenia in patients with chronic schizophrenia. In the second phase of the study, 4 chronic disease areas (two chronic disease areas for men and women) were randomly divided into experimental groups and control groups. The experimental group received a 16-week lower limb muscle strength training program, while the control group received routine care. The two groups conducted one pre-test and two post-tests, and the measurement content included physical function performance (Short Physical Performance Battery (SPPB), sarcopenia quality of life (SarQoL), and fall incidence). It is expected that the development of a set of non-pharmacological care measures will help patients in chronic psychiatric wards to become independent and slow down the progression of sarcopenia.

Status (registry)
Completed
Study type
Interventional
Enrollment
78 (actual)
First submitted
16 Jul 2024
Start date
20 Sept 2024
Primary completion date
16 Jan 2025
Lead sponsor
National Taipei University of Nursing and Health Sciences
NCT number
NCT07183969

What you commit to

  • Study type: Interventional
  • Participants enrolled: 78
  • From 20 Sept 2024 to the primary completion date, 16 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • (3) Those with severe psychiatric symptoms that prevent them from concentrating and following instructions.

Other

  • (1) Those who are unable to walk unaided.
  • (2) Severe structural disability that prevents the performance of lower extremity training.
  • (4)Participation in a lower extremity muscle training program or intervention within one year.

Who the study is looking for

  • (1) Suitable for participation in this study as assessed by the attending physician.
  • (2) After explaining the purpose of the study and the study process, family members and study subjects were asked to agree to participate in the study and to complete the consent form for signature.

Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tsaotun Psychiatric Center,MOHW
Coordinator of this site? Confirm its status
TsaotunTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.